Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study

The BMJ

Volumn 369, Issue , 2020, Pages

  Petrilli, Christopher M ^a,b   Jones, Simon A ^a,b   Yang, Jie ^b   Rajagopalan, Harish ^b   O'Donnell, Luke ^a   Chernyak, Yelena ^b   Tobin, Katie A ^b   Cerfolio, Robert J ^a,b   Francois, Fritz ^a,b   Horwitz, Leora I ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; TROPONIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BODY MASS; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMORBIDITY; CORONAVIRUS DISEASE 2019; CRITICAL ILLNESS; DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART FAILURE; HOSPICE CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION RISK; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MORTALITY; NEW YORK; OXYGEN SATURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SURVIVAL ANALYSIS; UNITED STATES; VITAL SIGN; CLINICAL FEATURE; CONTROLLED STUDY; HEALTH CARE QUALITY; LABORATORY TEST; MORTALITY RISK; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; UNIVERSITY HOSPITAL; YOUNG ADULT; AGE; BETACORONAVIRUS; CORONAVIRUS INFECTION; HOSPITALIZATION; PANDEMIC; VIRUS PNEUMONIA;

ADULT; AGE FACTORS; AGED; BETACORONAVIRUS; COMORBIDITY; CORONAVIRUS INFECTIONS; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; PANDEMICS; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; YOUNG ADULT;

EID: 85085528406     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.m1966     Document Type: Article

References (39)

1. Guan WJ, Ni ZY, Hu Y, et al, China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20. doi:10.1056/NEJMoa2002032
2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020. doi:10.1001/jama.2020.2648
3. Livingston E, Bucher K. Coronavirus disease 2019 (covid-19) in Italy. JAMA 2020. doi:10.1001/jama.2020.4344
4. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to covid-19 in Italy. JAMA 2020. doi:10.1001/jama.2020.4683
5. CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (covid-19)-United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343-6. doi:10.15585/mmwr.mm6912e2
6. CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382-6. doi:10.15585/mmwr.mm6913e2
7. Richardson S, Hirsch JS, Narasimhan M, et al, and the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City area. JAMA 2020. doi:10.1001/ jama.2020.6775
8. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. doi:10.1001/jamainternmed.2020.0994
9. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2020:ciaa272. doi:10.1093/cid/ciaa272
10. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. doi:10.1016/S0140-6736(20)30566-3
11. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (covid-19). JAMA Cardiol 2020. doi:10.1001/jamacardio.2020.1017
12. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. doi:10.1001/jama.2020.1585
13. Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention. Analysis on 54 mortality cases of coronavirus disease 2019 in the Republic of Korea from January 19 to March 10, 2020. J Korean Med Sci 2020;35:e132. doi:10.3346/jkms.2020.35. e132
14. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle Region-case series. N Engl J Med 2020. doi:10.1056/NEJMoa2004500
15. Grasselli G, Zangrillo A, Zanella A, et al, COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020. doi:10.1001/jama.2020.5394
16. NYC Health. Cases, hospitalizations and deaths. 2020. https://www1. nyc.gov/site/doh/covid/covid-19-data.page#download.
17. Popescu I, Fingar KR, Cutler E, Guo J, Jiang HJ. Comparison of 3 Safety-Net Hospital Definitions and Association With Hospital Characteristics. JAMA Netw Open 2019;2:e198577.
18. Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc 1992;87:178-83. doi:10.1080/01621459.1992.10475190
19. Imdad MU, Aslam M. mctest: multicollinearity diagnostic measures version 1.2.5 2018. https://CRAN.R-project.org/package=mctest.
20. Venables WN, Ripley BD. Modern Applied Statistics. 4th ed. Springer, 2002. doi:10.1007/978-0-387-21706-2
21. Venzon DJ, Moolgavkar SH. A method for computing profilelikelihood based confidence intervals. Appl Stat 1988;37:87-94. doi:10.2307/2347496
22. Fine JP, Grey RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509. doi:10.1080 /01621459.1999.10474144
23. Grey RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 2019;16:1141-54. doi:10.1214/aos/1176350951
24. Sfumato P. Goodness-of-fit for time-to-event data. 2020. https:// www.rdocumentation.org/packages/goftte/versions/1.0.5.
25. Melby C, Gu J, Rojanasakul M. Mapping New York City hospital beds as coronavirus cases surge. 2020 https://www.bloomberg.com/ graphics/2020-new-york-coronavirus-outbreak-how-many-hospitalbeds/.
26. World Health Organization. Hospital beds (per 10 000 population). 2020 https://www.who.int/data/gho/data/indicators/indicatordetails/ GHO/hospital-beds-(per-10-000-population).
27. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685-93. doi:10.1056/ NEJMoa050333
28. Bellani G, Laffey JG, Pham T, et al, LUNG SAFE Investigators, ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315:788-800. doi:10.1001/ jama.2016.0291
29. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock[published Online First: 2018/06/26]. Lancet 2018;392:75-87. doi:10.1016/S0140-6736(18)30696-2
30. Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection-Lancet Respir Med 2020;8:436-8. doi:10.1016/S2213-2600(20)30167-3
31. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000;181:831-7. doi:10.1086/315320
32. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012;54:1427-36. doi:10.1093/cid/cis211
33. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50. doi:10.1056/NEJMra021333
34. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association-Eur Heart J 2020:ehaa254. doi:10.1093/eurheartj/ehaa254
35. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020;S1931-5244(20)30070-0. doi:10.1016/j.trsl.2020.04.007
36. Schmidt FM, Weschenfelder J, Sander C, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One 2015;10:e0121971. doi:10.1371/journal.pone.0121971
37. Caer C, Rouault C, Le Roy T, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep 2017;7:3000. doi:10.1038/s41598-017-02660-w
38. Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond) 2018;132:1243-52. doi:10.1042/ CS20180306
39. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-60. doi:10.1161/01.CIR.86.3.1046